Dermatology and Therapy — Journal Profile & Submission Links
Adis, Springer Healthcare · ISSN-L 2190-9172
Source-backed journal profile with OpenAlex metadata and links to official submission resources for Dermatology and Therapy.
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- www.springer.com/journal/13555
- Author guidelines
- www.springer.com/journal/13555/submission-guidelines
Catalog scope notes
Aims and Scope Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world. Rapid Publication The journal aims for a 2-week peer review, and 3-4 weeks from acceptance to online. Please note that for any steps outside of our standard publication processes, such as multiple rounds of peer review or article proofs, or non-standard
Catalog source: scimago. This is not a copy of the publisher's author instructions.
Submission & timeline
- Submission portal
- Information not currently available.
- Average review time
- Information not currently available.
- Acceptance rate
- Information not currently available.
- Article types accepted
- Information not currently available.
- Publication frequency
- Information not currently available.
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.
